Evidence mapPaperPMID 41857346Full record

ReviewChirurgie (Heidelberg, Germany)2026

[Anorectal functional disorders following organ-preserving treatment and resection of rectal cancer].

Oliver Schwandner

Abstract readEnglish AbstractReview
PubMed Publisher
In one paragraph

Review in Chirurgie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Oliver SchwandnerAbteilung für Proktologie, Krankenhaus Barmherzige Brüder Regensburg, Prüfeninger Str. 86, 93049, Regensburg, Deutschland. oliver.schwandner@barmherzige-regensburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anorectal functional disorders following curative treatment for rectal cancer range from fecal incontinence to obstructed defecation and represent a symptom complex with tremendous impact on the quality of life in up to 70% of patients. Following resection, symptoms are defined as low anterior resection syndrome (LARS) and can be differentiated into minor LARS and major LARS. Independent factors predictive of LARS include total mesorectal excision, level of the anastomosis and neoadjuvant chemoradiotherapy. Therapeutic options include conservative management (dietary modification, stool regulation), pelvic floor rehabilitation and transanal irrigation. Sacral neuromodulation has been shown to be effective for major LARS. In general, multidisciplinary teams providing professional management according to patient-reported outcome measurements are mandatory. Based on the prevalence of anorectal functional disorders after resection and organ preservation, the description of symptoms restricted to LARS no longer seems appropriate and a new consensus-based definition should be developed.

Indexed as

Low Anterior Resection SyndromeOrgan Sparing TreatmentsPostoperative ComplicationsRectal NeoplasmsColorectal Surgical ProceduresFecal IncontinenceHumansQuality of LifeLow anterior resection syndromePatient-reported outcome measurementsPelvic floor rehabilitationPredictive factorsSacral neuromodulation

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.